Xagga tirakoobka tallaalka, xogta laga helay CDC waxay muujineysaa in qiyaastii 63.5% dadweynaha Mareykanka ay si buuxda uga tallaaleen COVID-19. Si kastaba ha ahaatee, tan iyo Thanksgiving, waxaa jiray ku dhawaad 84,000 oo dhimasho ah. Kala duwanaanshaha Omicron, in kasta oo uu ka yar yahay noocyada hore, haddana aad buu u faafayaa waxaana lagu qiyaasaa inuu ka dhigan yahay 99.9% dhammaan kiisaska cusub ee Maraykanka ilaa Janaayo. 22aad. Shalay, in ka badan 21 milyan oo kiisas cusub oo toddobaadle ah ayaa laga soo sheegay adduunka oo dhan, kuwaas oo ah kuwii ugu badnaa ee la diiwaan geliyo tan iyo bilowgii masiibada, sida ay sheegtay Ururka Caafimaadka Adduunka.
Natiijada tirada badan ee kiisaska cusub, xirmooyinka tijaabada ayaa gabaabsi ah. Sida laga soo xigtay Anthony S. Fauci, madaxa lataliyaha caafimaadka ee Madaxweyne Biden, waxay noqon doontaa mid aad muhiim u ah "inaan helno awood weyn oo tijaabo ah, gaar ahaan marka baahida baaritaanku aad u sarreeyo, oo ay weheliso isku darka kala duwanaanshaha Omicron laftiisa, iyo sidoo kale xilliga fasaxa, halkaas oo dadku ay rabaan inay helaan heerkaas dheeraadka ah ee hubinta in la ilaalinayo, xitaa haddii lagu tallaalo oo lagu kordhiyo."
Todos Medical Ltd. oo ay weheliso lammaanaheeda 3CL protease theranostic wadajirka ah ee NLC Pharma Ltd., ayaa lagu dhawaaqay shalay warar degdeg ah oo la xidhiidha, "xogta ku meel gaadhka ah ee Tollovir ™ ee ka hortagga fayraska afka ee 3CL protease inhibitor Wajiga 2 ee tijaabada caafimaad ee daaweynta cusbitaalka (aad u daran oo halis ah) ) Bukaannada COVID-19. Tollovir waxay la kulantay barteeda ugu dambeysa ee dhimista wakhtiga horumarka caafimaad sida lagu cabiray Nidaamka Digniinta Degdegga ah ee Qaranka 2 (NEWS2) wuxuuna la kulmay dhowr qodob oo muhiim ah oo heersare ah, oo ay ku jiraan dhimista dhammaystiran ee dhimashada COVID-19. Shirkaddu hadda waxay si rasmi ah u xidhay tijaabada caafimaadka Wajiga 2 sababtuna tahay xogta waxtarka ku meel gaarka ah ee togan. Xarunta caafimaadka ee hogaanka Shaare Zedek waxay hadda ogolanaysaa isticmaalka Tollovir™ bukaannada COVID-19 ee cusbitaalka ku jira si naxariis leh.
Waxaa sidoo kale loo diyaariyey horumarinta Tollovir ee daaweynta:
1) covid-19 carruurta isbitaalka jiifa
2) dhexdhexaad ilaa daran qof weyn oo COVID-19 ah oo ku jira goobta bukaan-socodka
3) dhexdhexaad ilaa daran COVID-19 carruurta ee goobta bukaan-socodka
4) daawaynta Long COVID ee dadka waaweyn
5) daaweynta Long COVID ee goobta carruurta
